Apollo Care Recalls Semaglutide Vials Over Particulate Matter
FDA classifies recall of 250 vials as Class II due to presence of nylon/polyamide and silk/proteinaceous-type material.
Every recalls & safety alerts report published for Columbia, Missouri, newest first.
FDA classifies recall of 250 vials as Class II due to presence of nylon/polyamide and silk/proteinaceous-type material.
The FDA has closed the recall of certain semaglutide vials distributed nationwide, citing the presence of particulate matter, as of August 19, 2026.
FDA classifies recall of 56,918 vials as Class II due to presence of nylon/polyamide and silk/proteinaceous-type material.
FDA classifies recall of 23,029 vials as Class II due to presence of particulate matter.
FDA classifies recall of 4,748 vials as Class II due to presence of particulate matter.
The agency has closed the recall of certain semaglutide vials due to particulate matter, considering the action carried out.
FDA classifies recall of 9,762 vials as Class II due to presence of particulate matter.
FDA classifies recall as Class II due to presence of particulate matter in certain lots of semaglutide injection vials.
On August 19, 2026, the FDA reported a recall of certain semaglutide vials distributed nationwide, citing the presence of particulate matter.
The FDA has closed the recall of certain semaglutide vials distributed nationwide, citing the presence of particulate matter.
FDA classifies recall of 37,546 vials as Class II due to presence of nylon/polyamide and silk/proteinaceous-type material.